Get started
Author

José Vicente Hervás

Observed names: J. V. Hervás, J. V. Hervás‐García, J.V. Hervás Garcia, J.V. Hervás-García, JV Hervás, Jose V Hervás, Jose V. Hervás-García, Jose Vicente Hervas, Jose Vicente Hervas-Garcia, Jose-Vicente Hervás-García, José V. Hervás-García, José V. Hervás‐García, José Vicente Hervás García, José Vicente Hervás-Garcia, José Vicente Hervás-García, José Vicente Hervás‐García
ORCID: 0000-0002-1132-0291
Observed ORCID: 0000-0002-1132-0291
OpenAlex ID: A5020962127
Effect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial
2022 · Natalia Pérez de la Ossa, Sònia Abilleira, et al. · JAMA · 217
PDF
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
2019 · L. Nogueras, H. Gonzalo, et al. · Scientific Reports · 63
PDF
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients
2018 · Bibiana Quirant‐Sánchez, José V. Hervás‐García, et al. · CNS Neuroscience & Therapeutics · 40
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
2019 · Hugo Gonzalo, Lara Nogueras, et al. · Frontiers in Neuroscience · 37
PDF
Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing–Remitting Multiple Sclerosis Patients
2016 · Aina Teniente‐Serra, José Vicente Hervás, et al. · CNS Neuroscience & Therapeutics · 33
PDF
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients
2017 · Joan Puñet‐Ortiz, José Vicente Hervás‐García, et al. · Cytometry Part B Clinical Cytometry · 23
PDF
Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
2019 · Bibiana Quirant-Sánchez, Silvia Presas-Rodriguez, et al. · Mediators of Inflammation · 15
PDF
Workflows and Outcomes in Patients With Suspected Large Vessel Occlusion Stroke Triaged in Urban and Nonurban Areas
2022 · Alvaro Garcia-Tornel, Monica Millan, et al. · Stroke · 14
Multiple Intracranial Arteriovenous Fistulas in Cowden Syndrome
2016 · Luis A. Prats-Sánchez, Jose V. Hervás-García, et al. · Journal of Stroke and Cerebrovascular Diseases · 14
Association of Time of Day With Outcomes Among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia
2023 · Álvaro García-Tornel, Alan Flores, et al. · Stroke · 13
Neurological symptoms following exposure to ozone
2012 · Dolores Vilas Rolán, Marta Milà Lopez, et al. · Journal of Neurology · 13
Effects of Vortioxetine on Cognition and Fatigue in Patients with Multiple Sclerosis and Depression: A Case Series Study
2023 · Anna Gil-Sanchez, Marc Canudes, et al. · CNS & Neurological Disorders - Drug Targets · 10
Gadolinium-enhanced brain lesions in multiple sclerosis relapse
2021 · L. Martín-Aguilar, S. Presas-Rodriguez, et al. · Neurología · 10
PDF
Progressive Multifocal Leukoencephalopathy Associated to Natalizumab Extended Dosing Regimen
2015 · José Vicente Hervás-García, Silvia Presas-Rodríguez, et al. · Neurodegenerative Disease Management · 10
Gadolinium-enhanced brain lesions in multiple sclerosis relapse
2022 · L. Martín-Aguilar, S. Presas-Rodriguez, et al. · Neurología (English Edition) · 9
PDF
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses
2015 · Cristina Ramo-Tello, Mar Tintoré, et al. · Multiple Sclerosis Journal · 8
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double‐blind, non‐inferiority trial
2018 · J. V. Hervás‐García, L. Ramió‐Torrentà, et al. · European Journal of Neurology · 6
Multineuritis craneal como comienzo de lupus eritematoso sistémico: un reto diagnóstico
2016 · A.M. Crespo Cuevas, J.V. Hervás Garcia, et al. · Neurología · 6
PDF
Mielitis. Diferencias entre esclerosis múltiple y otras etiologías
2015 · S. Presas-Rodríguez, L. Grau-López, et al. · Neurología · 6
PDF
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses
2014 · L Grau-López, A Teniente-Serra, et al. · Multiple Sclerosis Journal · 6
Myelitis: Differences between multiple sclerosis and other aetiologies
2016 · S. Presas-Rodríguez, L. Grau-López, et al. · Neurología (English Edition) · 5
PDF
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
2022 · Agustín Sancho-Saldaña, Anna Gil Sánchez, et al. · Journal of Clinical Medicine · 4
PDF
Hepatitis tóxica tras tratamiento concomitante con interferón beta y aloe vera en un paciente con esclerosis múltiple: a propósito de un caso
2016 · J.V. Hervás-García, E. Montané, et al. · Neurología · 4
PDF
Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report
2017 · J.V. Hervás-García, E. Montané, et al. · Neurología (English Edition) · 3
PDF
Encefalopatía y neuromielitis óptica: importancia del reconocimiento de la sintomatología atípica
2014 · José Vicente Hervás García, Laia Grau López, et al. · Revista de Neurología · 3
Works count: 39
Citation count: 575
H-index: 11
I10-index: 14
Year
Topic
Type